NCT05269160 2026-02-17
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)
Baylor College of Medicine
Phase 1/2 Terminated
Clinical Trials
10 trialsNCT05190770 2025-12-03
A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02142959 2025-06-03
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
Biogen
Phase 2 Completed
NCT04173247 2025-03-17
Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy
Wake Forest University Health Sciences
Phase NA Completed
NCT04067310 2024-12-09
Study Using Spray Skin Protector Versus Conventional Treatment to Prevent Acute Radiodermatitis.
Instituto Nacional de Cancer, Brazil
Phase NA Completed
NCT02369835 2024-01-30
Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Stanford University
Phase 3 Completed
NCT03255980 2020-12-16
Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid®
Helsinn Healthcare SA
Phase NA Completed
NCT02556632 2017-11-06
Curcumin-II
University of Rochester
Phase 2 Completed
NCT02534129 2017-10-06
Topical Use of Difinsa53â„¢ to Prevent Radiation Dermatitis
ProTechSure Scientific, Inc.
Phase 1/2 Terminated
NCT01246973 2016-03-07
Oral Curcumin for Radiation Dermatitis
University of Rochester
Phase 2/3 Completed